TY - JOUR
T1 - Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement
T2 - Updated reporting guidance for health economic evaluations
AU - Husereau, Don
AU - Drummond, Michael
AU - Augustovski, Federico
AU - De Bekker-Grob, Esther
AU - Briggs, Andrew H.
AU - Carswell, Chris
AU - Caulley, Lisa
AU - Chaiyakunapruk, Nathorn
AU - Greenberg, Dan
AU - Loder, Elizabeth
AU - Mauskopf, Josephine
AU - Mullins, C. Daniel
AU - Petrou, Stavros
AU - Pwu, Raoh Fang
AU - Staniszewska, Sophie
N1 - Funding Information:
We thank the following who participated in the study. The Editors Advisory Group: Wendy Babidge, Lyn Beamesderfer, Dior Beerens, Chris Carswell, Tillie Cryer, Ana Donnelly, Manuel Espinoza, Dan Greenberg, Wolfgang Greiner, Laura Happe, Mickaël Hiligsmann, Christine Laine, Lin Lee, Ken Lee, Elizabeth Loder, Natalie Pafitis, Julia Robinson Kenneth Stein, Eva Szunyogova, Wim Weber, Timothy Wrightson, and Brian Zikmund-Fisher. Participants in the Delphi Panel exercise: Marie-Claude Aubin, Marc Berger, John Campbell, Doug Coyle, Matthew Dyer Richard Edlin, Rita Faria, Veronica Gallegos, Alastair Gray, Scott Grosse, Jason Guertin, Dyfrig Hughes, Florencia Hutter, Denny John, Hanin Farhana Kamaruzaman, David Kim, Murray Krahn, Dan Moldaver, Ku Abd Rahim Ku Nurhasni, Daniela Vianna Pachito, Michael Paulden, Clinton Pecenka, Andrés Pichon-Riviere, John Powell, Lisa Prosser, Dean Regier, Anna Ringborg, Rossana Rivas, Chris Sampson, Marisa Santos, Paul Scuffham, Mark Sculpher, Katia Senna, Eldon Spackman, Lotte Steuten, David Tamblyn, Kilgore Trout, Dick Willke, and Torbjorn Wisloff. Additional ISPOR reviewers who commented on our drafts: Tadesse Abegaz, Alex Kostyuk, Kelly Lenahan, Nan Luo, Joshua Soboil, Richard White, and members of the PPIE. Thanks to David Moher for initial advice on approach, and a very special final thanks to Elizabeth Molsen. Contributors: DH is Task Force co-chair and the submitting and corresponding author; MD is a Task Force co-chair. All other authors (FA, EBG, AHB, CC, LC, NC, DG, EL, JM, CDM, SP, RFP, and SS-listed in alphabetical order by surname) and the co-chairs conceived this paper and designed the Delphi survey conducted to inform the guideline content. DH conducted a literature review, administered the Delphi survey and analysed the data for both. DH and MD prepared materials for each meeting and led the drafting and editing of the article. DH, MD, FA, AHB, EBG, CC, LC, NC, DG, EL, JM, CDM, SP, RFP, and SS drafted particular sections of the article. MD and SS led the PPIE advisory group. DH and CC led the Editors Advisory Group. All authors were involved in revising the article critically for important intellectual content. All authors approved the final version of the article. DH is the guarantor of this work. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. David Moher served as scientific advisor and reviewed the initial proposal as well as attended initial meetings; all members of the PPIE (Ivett Jakab, Emma Kinloch, Eric Low, Jean Mossman, Declan Noone, Phil Posner, and Jo Watson) critically reviewed the initial checklist and suggested and provided review and advice on subsequent drafts of the checklist and Explanation and Elaboration report. Members of the PPIE were invited to participate in the Delphi Panel exercise. All members of the PPIE, and Delphi Panel were invited to review drafts of the checklist and accompanying report. Funding: Funding to support ongoing meetings was provided by ISPOR - The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data. Competing interests: All authors have completed the ICMJE uniform disclosure form and declare no competing interests. Provenance and peer review: Not commissioned; externally peer reviewed. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
Publisher Copyright:
©
PY - 2022/1/11
Y1 - 2022/1/11
N2 - Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.
AB - Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.
UR - http://www.scopus.com/inward/record.url?scp=85123166179&partnerID=8YFLogxK
U2 - 10.1136/bmj-2021-067975
DO - 10.1136/bmj-2021-067975
M3 - Review article
C2 - 35017145
AN - SCOPUS:85123166179
SN - 0959-8146
VL - 376
JO - The BMJ
JF - The BMJ
M1 - e067975
ER -